Trinity biotech provides preliminary second quarter 2024 update and enters into uk distribution agreement with medscience

-second quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth-

TRIB Ratings Summary

TRIB Quant Ranking